Neurological Features During COVID19

Description of neurolOgical Involvement Observed During SARS COV2 Infection

Description of the neurological impairment: clinico-radiological and electrophysilogical correlations

Describe short and long term clinical radiological and electrophysilogical presentations of neurological damage central and peripheral SARS COV2 infection Describe the association between neurological, respiratory and dysautonomic Determine the prognosis of neurological damages to short and long term.

Inclusion Criteria:

• PCR SARS COV2 positive or CT Scan
• Central neurological signs such as confusion, epilepsy, abnormal movement, pyramidal signs, motor or sensory deficit, involvement of cranial pairs (such as anomie or ageusia) or peripheral.
• Dysautonomic signs such as hypotension or hypertension, bradycardia or tachycardia, hypothermia, SIADH not explained by therapy or a pathology other than SARS COV 2 infection

Exclusion Criteria:

• Contraindication to performing an MRI scan
• Minor
• Pregnant woman
• No follow-up possible at 6 months